Loading…

Retractable Technologies received a $54.2 million contract from the U.S. HHS for its syringes, covering a five-month period from Feb. 15, 2021 to July 14, 2021.
“Retractable Technologies (NYSE: RVP) announced that it received a government contract worth more than $54.2 million for its syringes.”massdevice.com
Summarized from public sources; check the original articles before acting on it.